COMPANY

Leukogene Therapeutics

HQ: Charleston, SC source · leukogene.com ↗ · Southeast

Keywords: cancer oncology acute myeloid leukemia pancreatic ductal adenocarcinoma

Location: Charleston, SC · source · Oct 15, 2026

Profile checked Oct 10, 2026

8NIH grants

Timeline

Aug 1, 2025 Grant Government grant — SBIR: $742,887 (annual award, as published), announced Aug 1, 2025. Agency: NIH/NCI. Source: government award database. source ↗

Funding

Last 2 years.

Aug 1, 2025 Government grant — SBIR: $742,887 (annual award, as published), announced Aug 1, 2025. Agency: NIH/NCI. Source: government award database. source ↗

NIH awards 8

Annual award amounts. Total $5.0M.

Jul 24, 2024 NIH award 5R44CA268138-03 FY2024: $742,887 awarded for that fiscal year; activity R44 (SBIR); PI ROBINSON, REEDER MCNEIL; recipient as written: LEUKOGENE THERAPEUTICS, INC., Charleston, SC. AGR2-superantigen vaccine source ↗
Jul 31, 2023 NIH award 4R44CA268138-02 FY2023: $782,691 awarded for that fiscal year; activity R44 (SBIR); PI ROBINSON, REEDER MCNEIL; recipient as written: LEUKOGENE THERAPEUTICS, INC., Charleston, SC. AGR2-superantigen vaccine source ↗
May 13, 2022 NIH award 1R42CA268138-01 FY2022: $671,746 awarded for that fiscal year; activity R42 (STTR); PI ROBINSON, REEDER MCNEIL; recipient as written: LEUKOGENE THERAPEUTICS, INC., Charleston, SC. AGR2-superantigen vaccine source ↗
Sep 24, 2021 NIH award 1R41CA265624-01 FY2021: $362,118 awarded for that fiscal year; activity R41 (STTR); PI DOLLOFF, NATHAN G.; recipient as written: LEUKOGENE THERAPEUTICS, INC., Charleston, SC. Bispecific T cell engagers for source ↗
May 17, 2019 NIH award 5R42CA213488-03 FY2019: $1,015,871 awarded for that fiscal year; activity R42 (STTR); PI MARCOUX, FRANK W.; recipient as written: LEUKOGENE THERAPEUTICS, INC., Charleston, SC. Proteasome inhibitor re-sensit source ↗
May 14, 2018 NIH award 2R42CA213488-02 FY2018: $984,129 awarded for that fiscal year; activity R42 (STTR); PI MARCOUX, FRANK W.; recipient as written: LEUKOGENE THERAPEUTICS, INC., Charleston, SC. Proteasome inhibitor re-sensitiz source ↗
Sep 22, 2016 NIH award 1R41CA213488-01 FY2016: $222,958 awarded for that fiscal year; activity R41 (STTR); PI MARCOUX, FRANK W.; recipient as written: LEUKOGENE THERAPEUTICS, INC., Charleston, SC. Proteasome inhibitor re-sensitiz source ↗
Sep 18, 2013 NIH award 1R41CA180255-01 FY2013: $224,701 awarded for that fiscal year; activity R41 (STTR); PI MARCOUX, FRANK W.; recipient as written: LEUKOGENE THERAPEUTICS, INC., Charleston, SC. Inhibitors of IgH Gene Enhancers source ↗